Sun Pharmaceutical Industries
Launch date
Employees
Market cap
CAD83.0b
Enterprise valuation
CAD80.0b (Public information from Sep 2024)
Share price
INR1849.90002 SUNPHARMA.NS
Mumbai Maharashtra (HQ)
Financials
Estimates*
INR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 331.4b | 384.3b | 432.8b | 477.6b | 531.5b | 590.0b | 631.5b |
% growth | 3 % | 16 % | 13 % | 10 % | 11 % | 11 % | 7 % |
EBITDA | 90.5b | 116.0b | 122.8b | 142.9b | 146.4b | 167.0b | 181.3b |
% EBITDA margin | 27 % | 30 % | 28 % | 30 % | 28 % | 28 % | 29 % |
Profit | 29.0b | 32.7b | 84.7b | 95.8b | 113.1b | 130.7b | 145.6b |
% profit margin | 9 % | 9 % | 20 % | 20 % | 21 % | 22 % | 23 % |
EV / revenue | 4.1x | 5.4x | 5.2x | 7.8x | 7.9x | 7.0x | 6.5x |
EV / EBITDA | 15.1x | 17.9x | 18.5x | 26.1x | 28.6x | 24.7x | 22.4x |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
N/A | Acquisition | ||
Total Funding | - |
Related Content
Recent News about Sun Pharmaceutical Industries
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
Investments by Sun Pharmaceutical Industries
EditACQUISITION by Sun Pharmaceutical Industries Nov 2012
ACQUISITION by Sun Pharmaceutical Industries Sep 2015
ACQUISITION by Sun Pharmaceutical Industries Jan 2023
ACQUISITION by Sun Pharmaceutical Industries Apr 2014
exited
exited
ACQUISITION by Sun Pharmaceutical Industries Nov 2016